Wuzi Yanzong pill attenuates MPTP-induced Parkinson's Disease via PI3K/Akt signaling pathway.

MLA

Hang, Wei, et al. “Wuzi Yanzong Pill Attenuates MPTP-Induced Parkinson’s Disease via PI3K/Akt Signaling Pathway.” Metabolic Brain Disease, vol. 37, no. 5, June 2022, pp. 1435–50. EBSCOhost, https://doi.org/10.1007/s11011-022-00993-8.

APA

Hang, W., Fan, H.-J., Li, Y.-R., Xiao, Q., Jia, L., Song, L.-J., Gao, Y., Jin, X.-M., Xiao, B.-G., Yu, J.-Z., Ma, C.-G., & Chai, Z. (2022). Wuzi Yanzong pill attenuates MPTP-induced Parkinson’s Disease via PI3K/Akt signaling pathway. Metabolic Brain Disease, 37(5), 1435–1450. https://doi.org/10.1007/s11011-022-00993-8

Chicago

Hang, Wei, Hui-Jie Fan, Yan-Rong Li, Qi Xiao, Lu Jia, Li-Juan Song, Yao Gao, et al. 2022. “Wuzi Yanzong Pill Attenuates MPTP-Induced Parkinson’s Disease via PI3K/Akt Signaling Pathway.” Metabolic Brain Disease 37 (5): 1435–50. doi:10.1007/s11011-022-00993-8.